Head-to-head · WeighScore
Peter MD vs T2D.com
The verdict
Peter MD takes it — 78.1/100 to 53/100.
Peter MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A Miami-founded telehealth that starts tirzepatide at $149 the first month (then $249/mo, billed quarterly) and runs semaglutide, TRT, sermorelin and NAD+ on the same account.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Peter MD | T2D.com |
|---|---|---|
| WeighScore | 78.1/100 | 53/100 |
| Grade | C+ | C |
| Site position | #34 | #516 |
| Semaglutide | $139-149/mo (compounded w/ B12) | $999/mo (starting dose, compounded) |
| Tirzepatide | $149 first month, then $249/mo (quarterly) | $999/mo (starting dose, compounded) |
| Coverage | Most states — exclusions vary by treatment | 1 state |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Site position #34 · C+
Strengths
- Broad multi-category catalog on one account — TRT, GLP-1, ED, non-GLP-1 weight loss, men's hair loss and NAD+
- Physician-prescribed, nationwide telehealth operating since 2021
- Genuinely cheap TRT entry — $79/mo testosterone cypionate on a 12-month plan
- Low tirzepatide first-month rate ($149) at a real 60mg dose
Where it loses points
- Tirzepatide steps up from $149 the first month to $249/mo, billed quarterly
- Semaglutide's own pricing is hard to compare at a glance — $149/mo for first-time patients vs $139/mo for returning ones, with very different total costs ($447 vs $834) over similar supply windows
- The affiliate program discloses a wider list of state exclusions (varying by treatment, touching AL, AR, CA, ID, IA, KY, LA, MA, MI, NC, SC and TX) than any single customer-facing pricing page states
- TRT and tirzepatide both require locking into quarterly or 12-month billing to get the advertised rate
- No named medical director or lab/monitoring detail published; customer reviews are mixed
Site position #516 · C
Strengths
- Built specifically for type 2 diabetic and pre-diabetic patients
- Integrated service — prescriber, pharmacy, and delivery handled in one flow
- Offers both compounded semaglutide and compounded tirzepatide
- Temperature-controlled home delivery via UPS or FedEx
- Ongoing prescriber monitoring and support included
Where it loses points
- No pricing published on the public website — must register to see costs
- No states list published on the site
- Newer brand with limited independent reviews
- Compounded only — no brand-name Ozempic, Wegovy, or Mounjaro
Featured provider
Peter MD
Peter MD scores 78.1/100 (C+). A Miami-founded telehealth that starts tirzepatide at $149 the first month (then $249/mo, billed quarterly) and runs semaglutide, TRT, sermorelin and NAD+ on the same account.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.